首页> 外国专利> METHOD OF CLOPIDOGREL-BASED CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITRIC OXIDE DEFICIENCY

METHOD OF CLOPIDOGREL-BASED CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITRIC OXIDE DEFICIENCY

机译:L-名字引起的一氧化氮缺乏症基于内皮糖化的内皮功能障碍矫正方法

摘要

FIELD: medicine.;SUBSTANCE: invention concerns medicine, particularly experimental cardiology and pharmacology, and can be used for correction of endothelial dysfunction that is ensured by simulation of endothelial dysfunction in experiment by daily intraperitoneal introduction to Wistar male rats of N-nitro-L-arginine methyl ester in a dose 25 mg/kg, within 7 days. Correction of dysfunction is carried out daily within 7 days by intragastric introduction of Clopidogrel in a dose 6.5 mg/kg. Degree of dysfunction development is determined by relation of endothelium-independent to endothelium-dependent vasodilation.;EFFECT: method provides correction of endothelial dysfunction in specific simulation environment.;2 tbl
机译:技术领域:本发明涉及医学,尤其是实验性心脏病学和药理学,并且可以用于校正内皮功能障碍,该内皮功能障碍是通过每天腹膜内引入Wistar雄性N-硝基-L雄性大鼠的实验模拟内皮功能障碍来确保-精氨酸甲酯,剂量为25 mg / kg,在7天内。通过在胃内引入剂量为6.5 mg / kg的氯吡格雷,每天7天内进行功能障碍的纠正。功能障碍的发展程度取决于内皮独立性与内皮依赖性血管舒张的关系。效果:该方法可校正特定模拟环境中的内皮功能障碍。2

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号